Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/19/2007EP1551370B1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
12/19/2007EP1546152B1 Epothilone derivatives
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1496911B1 Use of a combination comprising a2a adenosine receptor agonists and anti-pathogenic agents for the treatment of inflammatory diseases
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1490045A4 In vivo use of glutathionone s-transferase activated nitric oxide donors
12/19/2007EP1487285B1 Alertness bar
12/19/2007EP1485102A4 Sequential therapy comprising a 20(s)-camptothecin compound and a pyrimidine base analog
12/19/2007EP1480651B1 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1465875B1 Novel alkansulfonamides as endothelin antagonists
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
12/19/2007EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
12/19/2007EP1420802B1 Increased solubility flavanolignan preparations
12/19/2007EP1411921B1 Pharmaceutical compositions containing terbinafine and use thereof
12/19/2007EP1408949B1 Glycine betaine and its use as anti-hemorrhagic agent
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/19/2007EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1339665B1 Nitroderivatives as drugs for diseases having an inflammatory basis
12/19/2007EP1335719B1 Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis
12/19/2007EP1326873A4 Combinatorial libraries of monosaccharides
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1318788B1 Solid dose nanoparticulate compositions
12/19/2007EP1303599B1 Methylated nucleotide regulation of upa gene expression
12/19/2007EP1295870B1 Suplatast tosilate crystals
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
12/19/2007EP1286999B1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
12/19/2007EP1284729A4 A(beta)42 lowering agents
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007EP1156815B1 Process for extracting polyphenolic antioxidants from purine-containing plants
12/19/2007EP1120111B1 Method for stabilising an active substance in a tablet
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1100432B1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP1011678B1 Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
12/19/2007EP1005341B1 Il-8 receptor antagonists
12/19/2007EP0954578B1 Glycoprotein hormone (tsh) superagonists
12/19/2007EP0912091B1 Use of gaba uptake inhibitors as anti-tussive agents
12/19/2007EP0804440B1 Tricyclic benzazepine vasopressin antagonists
12/19/2007CN200991341Y Uterine-cavity shape intrauterine device
12/19/2007CN101090908A Conjugates with anti-inflammatory activity
12/19/2007CN101090902A Cgrp受体拮抗剂 Cgrp receptor antagonists
12/19/2007CN101090901A Hexahydropyridoisoqinolines as DPP-IV inhibitors
12/19/2007CN101090900A Process for preparation of high-purity meloxicam and meloxicam potassium salt
12/19/2007CN101090899A 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN101090896A Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
12/19/2007CN101090895A Aryl sulphonamide modulators
12/19/2007CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors
12/19/2007CN101090891A Methods for treating diseases with 4-hydroxybenzomorphans
12/19/2007CN101090888A 4-aminopiperidine derivatives
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN101090738A Matrix type sustained-release preparation containing basic drug or salt thereof
12/19/2007CN101090737A Matrix type sustained-release preparation
12/19/2007CN101090736A Stable emulsion compositions for intravenous administration having preservative efficacy
12/19/2007CN101090733A Enhanced bioavailability using laser resonant homogenization
12/19/2007CN101090727A Intraoral disintegration type solid preparation containing povidone iodine
12/19/2007CN101090726A Cladribine regimen for treating multiple sclerosis
12/19/2007CN101090725A Pharmaceutical composition comprising an ointment and two solubilized active principles
12/19/2007CN101090724A Heterocyclic derivatives and their use as therapeutic agents
12/19/2007CN101090723A Piperazine urea derivatives for the treatment of endometriosis
12/19/2007CN101090722A 镇痛剂 Analgesics
12/19/2007CN101090721A Selective serotonin receptor inverse agonists as therapeutics for disease
12/19/2007CN101090720A Nanoparticulate compositions of tubulin inhibitor compounds
12/19/2007CN101090719A Injectable or orally deliverable formulations of azetidine derivatives
12/19/2007CN101090718A Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same
12/19/2007CN101090717A Methods for regulating weight and size of animals
12/19/2007CN101090716A Treatment of HCV disorders
12/19/2007CN101090715A Dendritic cell infiltrativity activating composition and immune activator
12/19/2007CN101090714A Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
12/19/2007CN101090713A Method of providing fast relief to a user of a nicotine chewing gum
12/19/2007CN101090709A Nebulizer formulation
12/19/2007CN101090708A Plastic bottle for oxaliplatin solution
12/19/2007CN101090707A Medicament for hygienic application inside the ear
12/19/2007CN101090632A Modulation of bio-electrical rhythms via a novel engineering approach
12/19/2007CN101089010A 2'-fluoroncucleosides
12/19/2007CN101089008A Dicyclic analog without ring A and ring B of omithogalum caudatum OSW-1 saponin and its synthesis process and use
12/19/2007CN101089004A New type of phosphonate-nucleotide compound
12/19/2007CN101089000A Spiro piperazine quaternary ammonium salt compound and its prepn and application
12/19/2007CN101088998A Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/19/2007CN101088997A Improved process of preparing Raltitrexed
12/19/2007CN101088982A Fenofibrate derivative containing nitric ester and its medicinal use
12/19/2007CN101088563A Anticancer composition containing lomustine
12/19/2007CN101088562A Anticancer composition containing ranimustine
12/19/2007CN101088552A Psoriasis treating method
12/19/2007CN101088547A Application of Yin-nourishing medicine in preparing gene medicine for regulating vascular endothelial cell
12/19/2007CN101088522A Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn
12/19/2007CN101088521A Astragalus medicine prepn and its prepn process
12/19/2007CN101088518A Medicine prepn for reducing blood sugar and regulating blood pressure
12/19/2007CN101088517A Process of making sweel cool health myrobalan fruit
12/19/2007CN101088510A Medicinal use of cordycepic polysaccharide
12/19/2007CN101088509A Nutritious health oral liquid of lily polysaccharide
12/19/2007CN101088508A New medicinal use and medicine prepn of lily polysaccharide
12/19/2007CN101088507A Application of ophiopogoni D in preparing gene medicine for regulating vasular endothelial cell period
12/19/2007CN101088506A Application of ophiopogonin D in preparing gene medicine for regulating vascular endothelial cell fucntion
1 ... 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 ... 7860